Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 1
1977 1
1978 2
1979 1
1980 1
1981 2
1983 2
1984 2
1985 1
1986 3
1988 1
1989 2
1990 5
1991 2
1992 1
1993 1
1994 6
1995 2
1996 1
1997 5
1998 2
1999 4
2000 1
2001 1
2002 4
2004 2
2005 3
2006 2
2007 3
2008 7
2009 4
2010 7
2011 5
2012 3
2013 6
2014 3
2015 4
2016 4
2017 2
2018 6
2019 6
2020 9
2021 9
2022 10
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

PubMed for id: 235539

145 results

Results by year

Filters applied: . Clear all
Page 1
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.
Echavidre W, Durivault J, Gotorbe C, Blanchard T, Pagnuzzi M, Vial V, Raes F, Broisat A, Villeneuve R, Amblard R, Garnier N, Ortholan C, Faraggi M, Serrano B, Picco V, Montemagno C. Echavidre W, et al. Cancer Res Commun. 2023 Dec 7;3(12):2483-2496. doi: 10.1158/2767-9764.CRC-23-0298. Cancer Res Commun. 2023. PMID: 38009896 Free PMC article.
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
Peyrl A, Chocholous M, Sabel M, Lassaletta A, Sterba J, Leblond P, Nysom K, Torsvik I, Chi SN, Perwein T, Jones N, Holm S, Nyman P, Mörse H, Öberg A, Weiler-Wichtl L, Leiss U, Haberler C, Schmook MT, Mayr L, Dieckmann K, Kool M, Gojo J, Azizi AA, André N, Kieran M, Slavc I. Peyrl A, et al. JAMA Oncol. 2023 Dec 1;9(12):1688-1695. doi: 10.1001/jamaoncol.2023.4437. JAMA Oncol. 2023. PMID: 37883081 Free PMC article. Clinical Trial.
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK. Gregory TA, et al. Neurooncol Adv. 2023 Apr 13;5(1):vdad032. doi: 10.1093/noajnl/vdad032. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37114244 Free PMC article.
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
Tringale KR, Wolden SL, Karajannis M, Haque S, Pasquini L, Yildirim O, Rosenblum M, Benhamida JK, Cheung NK, Souweidane M, Basu EM, Pandit-Taskar N, Zanzonico PB, Humm JL, Kramer K. Tringale KR, et al. J Neurooncol. 2023 Mar;162(1):69-78. doi: 10.1007/s11060-022-04235-w. Epub 2023 Feb 28. J Neurooncol. 2023. PMID: 36853490 Free PMC article. Clinical Trial.
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.
Slavc I, Mayr L, Stepien N, Gojo J, Aliotti Lippolis M, Azizi AA, Chocholous M, Baumgartner A, Hedrich CS, Holm S, Sehested A, Leblond P, Dieckmann K, Haberler C, Czech T, Kool M, Peyrl A. Slavc I, et al. Cancers (Basel). 2022 Oct 19;14(20):5128. doi: 10.3390/cancers14205128. Cancers (Basel). 2022. PMID: 36291912 Free PMC article.
Unleashing the Mystery of a Treated Case of Medulloblastoma.
Ashtekar RM, Epari S, Shetty PM, Sahu AA. Ashtekar RM, et al. Indian J Radiol Imaging. 2022 Jul 31;32(3):416-421. doi: 10.1055/s-0042-1753466. eCollection 2022 Sep. Indian J Radiol Imaging. 2022. PMID: 36177290 Free PMC article.
145 results